Old API Wind-down Ltd - Ordinary Shares ARLZQ

RE:RE:RE:Tribute Shares now worth 75c

[GoldenDilemma]

snootchybootchy wrote:

select1011 wrote: Totally agree. Adams likely wasn't even in the "global office" this morning. They still answer the phone as Tribute. That was the most rambling conference call I have been on, blah, blah blah yospralla, later, blah blah blah ..."execution"......blah blah...how about a pint chaps......strategic platform.....blah.

I finally got a chance to listen to the conference call this evening and did not find it rambling at all.  Mr. Adams sounded like a man who is getting all his ducks in a row to support the current Aralez pipeline but at the same time, was careful not to tip his hand too much or to overpromise.  He certainly put me at ease regarding the cash burn.  Near the end of the conference call, a caller brought up the possibility of Yosprala being approved much sooner (I think he mentioned two months instead of six).  Mr. Adams was careful to tame expectations but it seems like this is a possibility.  This would explain why Mr. Adams has already built much of his sales force, as he mentioned that 20 people (out of a planned 25-person team to support the marketing and sales of Yosprala) have already accepted job offers.  So there may be a near-term catalyst (30 days) when the FDA issues their acknowledgement letter to the NDA.   

Light a candle and say a prayer to the stock Gods that approval comes faster than Q4 2016. Our upside will continued to be minimalized by then. Near term catalyst on acknowledgment isn't gonna mean much.

And, not that it means much, but Chardan just cut PT on Aralez from $15.50 to $10.